Rochester,NY 8/26/2009 12:50:48 AM
Pfizer Inc. PFE, opens biotech drug making plant in Sweden
Pfizer Inc.
Pfizer says it has opened $215 million biotechnology facility in Strangnas, Sweden.
Drugmaker Pfizer Inc. said Tuesday it opened a new biotech facility in Sweden, which will be used to make products including a branded version of human growth hormone.
Pfizer said it invested 150 million Euros ($214.8 million) in the plant in Strangnas. The facility is 6,000 square meters, or about 64,600 square feet. Products made at the plant will include Pfizer's human growth hormone, or Genotropin, along with the drug Somavert for acromegaly, and drugs based on E. coli and yeast.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
